Background
Materials and methods
Microarray data
Data processing
Functional and pathway enrichment analysis
Protein–protein interaction (PPI) network generation and module analysis
Validation of the target genes in TCGA
Immunohistochemistry
Results
Identification of aberrantly methylated DEGs in PCa
GO functional enrichment analysis
Category | Term | Count | P value |
---|---|---|---|
Hypomethylated with high expression | |||
GOTERM_BP_DIRECT | GO:0000122 —negative regulation of transcription from RNA polymerase II promoter | 41 | 5.49E−05 |
GOTERM_BP_DIRECT | GO:0001649 —osteoblast differentiation | 12 | 1.99E−04 |
GOTERM_BP_DIRECT | GO:0035556 —intracellular signal transduction | 25 | 6.61E−04 |
GOTERM_BP_DIRECT | GO:0007223 —Wnt signalling pathway, calcium-modulating pathway | 7 | 8.00E−04 |
GOTERM_BP_DIRECT | GO:0030036 —actin cytoskeleton organization | 12 | 0.0013 |
GOTERM_CC_DIRECT | GO:0005654 —nucleoplasm | 111 | 8.73E−05 |
GOTERM_CC_DIRECT | GO:0005829 —cytosol | 126 | 1.97E−04 |
GOTERM_CC_DIRECT | GO:0016604 —nuclear body | 6 | 0.0021 |
GOTERM_CC_DIRECT | GO:0005737 —cytoplasm | 176 | 0.0030 |
GOTERM_CC_DIRECT | GO:0032580 —Golgi cisterna membrane | 8 | 0.0054 |
GOTERM_MF_DIRECT | GO:0005515 —protein binding | 297 | 2.57E−04 |
GOTERM_MF_DIRECT | GO:0044212 —transcription regulatory region DNA-binding activity | 16 | 0.0016 |
GOTERM_MF_DIRECT | GO:0016874 —ligase activity | 18 | 0.0027 |
GOTERM_MF_DIRECT | GO:0005096 —GTPase activator activity | 18 | 0.0037 |
GOTERM_MF_DIRECT | GO:0003713 —transcription coactivator activity | 16 | 0.0066 |
Hypermethylated with low expression | |||
GOTERM_BP_DIRECT | GO:0043410 —positive regulation of MAPK cascade | 8 | 8.37E−05 |
GOTERM_BP_DIRECT | GO:0006936 —muscle contraction | 9 | 1.41E−04 |
GOTERM_BP_DIRECT | GO:0007568 —ageing | 11 | 2.19E−04 |
GOTERM_BP_DIRECT | GO:0007165 —signal transduction | 37 | 2.44E−04 |
GOTERM_BP_DIRECT | GO:0014068 —positive regulation of phosphatidylinositol 3-kinase signalling | 7 | 3.77E−04 |
GOTERM_CC_DIRECT | GO:0005925 —focal adhesion | 24 | 1.01E−03 |
GOTERM_CC_DIRECT | GO:0009986 —cell surface | 25 | 1.34E−03 |
GOTERM_CC_DIRECT | GO:0070062 —extracellular exosome | 74 | 2.77E−03 |
GOTERM_CC_DIRECT | GO:0042383 —sarcolemma | 9 | 3.60E−03 |
GOTERM_CC_DIRECT | GO:0005615 —extracellular space | 41 | 1.24E−02 |
GOTERM_MF_DIRECT | GO:0003779 —actin binding | 16 | 1.37E−04 |
GOTERM_MF_DIRECT | GO:0005515 —protein binding | 184 | 7.99E−04 |
GOTERM_MF_DIRECT | GO:0030165 —PDZ domain binding | 8 | 8.30E−04 |
GOTERM_MF_DIRECT | GO:0005539 —glycosaminoglycan binding | 4 | 0.0037 |
GOTERM_MF_DIRECT | GO:0004714 —transmembrane receptor protein tyrosine kinase activity | 5 | 0.0044 |
KEGG pathway analysis
Category | Term | Count | P value | Gene |
---|---|---|---|---|
Hypomethylated with high expression | ||||
KEGG_PATHWAY | hsa04152: AMPK signalling pathway | 12 | 0.0025 |
AKT1, IGF1R, PDPK1, IRS2, CCND1, TSC2, ACACA, FASN, FBP1, EEF2, PPP2R2D, RPTOR
|
KEGG_PATHWAY | hsa05200: pathways in cancer | 24 | 0.0062 |
HSP90AB1, DVL3, CTBP1, ADCY1, COL4A1, ADCY7, RXRA, CREBBP, GNA12, LEF1, FZD4, TCF7L2, TPM3, DAPK1, AKT1, JUP, IGF1R, WNT7B, CBLB, CCND1, GNB2, GNB1, CASP8, GNG7
|
KEGG_PATHWAY | hsa04520: adherens junction | 8 | 0.0094 |
ACTG1, IGF1R, TJP1, WASF3, BAIAP2, CREBBP, LEF1, TCF7L2
|
Hypermethylated with low expression | ||||
KEGG_PATHWAY | hsa05412: arrhythmogenic right ventricular cardiomyopathy (ARVC) | 8 | 3.99E−04 |
DES, SGCG, DMD, ITGA7, ITGA1, CACNB2, GJA1, CTNNB1
|
KEGG_PATHWAY | hsa04510: focal adhesion | 12 | 0.0020 |
CAV2, ITGA7, ITGA1, PDGFC, PTEN, FLNA, PIK3R1, MYLK, COL4A6, KDR, CTNNB1, PRKCB
|
KEGG_PATHWAY | hsa05410: hypertrophic cardiomyopathy (HCM) | 7 | 0.0038 |
DES, SGCG, DMD, ITGA7, ITGA1, CACNB2, TPM1 1
|
KEGG_PATHWAY | hsa05414: dilated cardiomyopathy | 7 | 0.0054 |
DES, SGCG, DMD, ITGA7, ITGA1, CACNB2, TPM1
|
KEGG_PATHWAY | hsa04151: PI3K-Akt signalling pathway | 15 | 0.0063 |
FGFR2, ITGA1, KITLG, KIT, LPAR1, PTEN, COL4A6, KDR, EIF4B, CDKN1B, ITGA7, ANGPT1, PDGFC, FGF2, PIK3R1
|
PPI network construction and cytoHubba analysis
Category | Rank method in cytoHubba | Top 30 genes |
---|---|---|
Hypomethylated with high expression | Betweenness |
AKT1, PRDM10,
ACACA, GNB1, DICER1, CTBP1, ACTG1, CREBBP, HSP90AB1, DCY7, GNG7, PXN, POLR2D, PPP3CA, EEF2, BGN, GNB2, EHMT2,
FASN, CCND1
, OXA1L, SHMT2, CBLB, ATP5B, UBE4A, RPL6, SYNJ2, TCF7L2, EPHB2, FAF2
|
Bottleneck |
AKT1, PRDM10
, ACACA, DICER1, GNB1, ADCY7, CTBP1, SH3RF1, EHMT2, CREBBP, PPP3CA, ACTG1,
FASN
, RPL6, JUP, OXA1L, BGN, HSP90AB1, PXN, ECHS1, ATP5B, GPT2, POLR2D,
CCND1
, SYNJ2, SHMT2, EIF4A1, USP7, CHEK1, EEF2
| |
Closeness |
AKT1, PRDM10,
ACACA, GNB1,
CCND1
, CTBP1, GNG7, DICER1, CREBBP, ADCY7, GNB2, PXN, IGF1R, PPP3CA, HSP90AB1, LEF1, EIF4A1, PDPK1, ITPR3, RPTOR, EHMT2, CHEK1, ACTG1, POLR2D, YWHAG, TCF7L2, EEF2,
FASN
, EPHB2, POLR3A
| |
Radiality |
AKT1, PRDM10
, ACACA,
CCND1,
CTBP1, DICER1, CREBBP, PPP3CA, IGF1R, GNB1, ADCY7, LEF1, PXN, EIF4A1, GNB2, HSP90AB1, GNG7, RPTOR, ITPR3, YWHAG, PDPK1, CHEK1, EHMT2, ACTG1, CASP8, TJP1,
FASN
, TSC2, EPHB2, TCF7L2
| |
Stress |
AKT1, PRDM10
, ACACA, GNB1, DICER1, CTBP1, ADCY7, GNG7, HSP90AB1, CREBBP, ACTG1, GNB2, POLR2D, PPP3CA, PXN, CBLB, EEF2,
CCND1
, EHMT2, BGN, TCF7L2, UBE4A, ATP5B, IGF1R, SYNJ2, POLR3A,
FASN
, SHMT2, EIF4A1, CHEK1
| |
Hypermethylated with low expression | Betweenness |
CTNNB1, DPYD, FGF2, VCAM1, PTEN, KIT, CFTR, RHOB, DCN, KDR, DMD, ANXA2,
PRKCB
, PRKG2, DES,
FLNA
, FST, KAT2B, PIK3R1, ITGA1, FOXO1, TPM1, PDE4D, ACSS3, CCK, KITLG, NT5E, CUL1, GATA3, HOPX
|
Closeness |
CTNNB1, FGF2, PTEN, KIT, VCAM1, KDR, PIK3R1, FOXO1, KITLG, DPYD, PROM1, CDKN1B, RHOB, LEPR, GJA1,
PRKCB
, KAT2B, ANXA2, DCN, SNAI2, DES, FGFR2, ITGA1, CUL1,
FLNA
, NT5E, CFTR, CCK, ANGPT1, PRKG2
| |
Degree |
CTNNB1, FGF2, PTEN,KIT, VCAM1, KDR, KITLG, PIK3R1, KAT2B, CUL1, DPYD, RHOB, FOXO1,
FLNA
, CDKN1B, DES, DCN,
PRKCB,
ITGA1, DMD, CCK, CFTR, ANXA2, PROM1, UBE3A, TPM1, PRKG2, NT5E, LEPR, FGFR2
| |
Eccentricity | VCAM1, ANXA2, KIT, FGF2, KDR, PIK3R1, DMD, GJA1, PRKCB, PRKG2, TMOD1, ITGA1, COCH, CCK, AVPR1A, MTUS1, EDNRA, MYOF, FLNA, CFTR, CXCL1, LPAR1, ANXA6, GSN, PDE4D, NT5E, COL4A6, HLA-F, TRIM29, DAB1 | |
Edge percolated component (EPC) |
FGF2, CTNNB1, KIT, PTEN, KDR, VCAM1, KITLG, PIK3R1, PROM1, CDKN1B, FOXO1, CUL1, KAT2B, ITGA1, FGFR2, ANGPT1, GJA1, DES, SNAI2, RHOB, UBE3A,
FLNA, PRKCB
, CCK, LEPR, CUL2, NT5E, TNS1, DCN, ANXA2
|
Module analysis
Category | Module | Score | Nodes | Enrichment and pathway description | Genes |
---|---|---|---|---|---|
Hypomethylated with high expression | 1 | 12.00 | 12 | GO:0016874—ligase activity GO:0004842—ubiquitin protein transferase activity GO:0000209—protein polyubiquitination hsa04120: ubiquitin-mediated proteolysis GO:0071377—cellular response to glucagon stimulus |
TRIM36, HERC3, NEDD4L, UBE4A, CBLB, SH3RF1, ASB13, MYLIP, RNF220, UBA1, UBE2H, RBBP6
|
2 | 10.00 | 10 | GO:0007186—G-protein-coupled receptor signalling pathway GO:0007193—adenylate cyclase-inhibiting G-protein-coupled receptor signalling pathway hsa04727: GABAergic synapse |
ADCY7, GNB1, GNB2, GNG7, ADCY1, DRD3, HTR1E, SST, RLN3, ADRA2A
| |
3 | 8.889 | 10 | GO:0005634—nucleus GO:0005515—protein binding GO:0006260—DNA replication hsa04110: cell cycle | CENPF, E2F8, TK1, HJURP, MCM3, ZWINT, MELK, CDKN3, EXO1, CHEK1 | |
4 | 7.00 | 7 | GO:0030669—clathrin-coated endocytic vesicle membrane GO:0060071—Wnt signalling pathway, planar cell polarity pathway GO:0035615—clathrin adaptor activity hsa04144: endocytosis |
FZD4, REPS2, ADRB2, SYNJ2, AP2M1, AP2A2, AAK1
| |
5 | 5.20 | 16 | GO:0006383—transcription from RNA polymerase III promoter GO:0003899—DNA-directed RNA polymerase activity GO:0032481—positive regulation of type I interferon production hsa00230: purine metabolism |
POLR2D, GUCY2F, TCF7L2, POLR1D, EEF2, POLR3H, GUCY1A3, SNAPC4, TCEANC, JUP, WNT7B, CTBP1, DVL3, BRF1, CREBBP, POLR3A
| |
6 | 3.444 | 19 | GO:0001649—osteoblast differentiation GO:0030206—chondroitin sulfate GO:0005515—protein binding hsa05222: focal adhesion |
FHIT, COL4A1, DROSHA, NUMA1, DDX21, CMKLR1, COL3A1, DICER1, B3GALT6, OXA1L, MEF2D, FUS, DNMT3B, ARFIP2, VCAN, THBS2, CCND1, XYLT1, AKT1
| |
7 | 3.143 | 8 | GO:0009058—biosynthetic process GO:0005759—mitochondrial matrix GO:0030170—pyridoxal phosphate binding hsa01230: biosynthesis of amino acids |
GPT2, FASN, GOT2, RPTOR, ATP5B, TSC2, PRDM10, SHMT2
| |
Hypermethylated with low expression | 1 | 6.00 | 13 | GO:0016032—viral process GO:0048015—phosphatidylinositol-mediated signalling GO:0061630—ubiquitin protein ligase activity hsa05200: pathways in cancer |
CUL2, PIK3R1, UBE3A, PTEN, PROM1, FBXL3, KITLG, KIT, KLHL2, FBXO17, CUL1, VCAM1, UBE2V2
|
2 | 3.667 | 7 | GO:0007202—activation of phospholipase C activity GO:0010595—positive regulation of endothelial cell migration GO:0008284—positive regulation of cell proliferation |
ANGPT1, FGF2, LPAR1, EDNRA, KDR, AVPR1A, CCK
| |
3 | 3.333 | 7 | hsa04015: Rap1 signalling pathway GO:0045944—positive regulation of transcription from RNA Polymerase II promoter GO:0005654—nucleoplasm |
HLA-F, IRF2, PPARGC1A, TRIM29, CDK8, CEBPB, KAT2B
|
Identification and validation of the six selected genes
Category | Hub gene | Expression status | P value | Methylation status | P value |
---|---|---|---|---|---|
Hypomethylated with high expression |
AKT1
| Upregulated | 0.0063 | Hypomethylated | 7.17E−07 |
PRDM10
| Upregulated | 0.0031 | Hypomethylated | 4.62E−10 | |
CCND1
| – | – | Hypomethylated | 5.98E−19 | |
FASN
| Upregulated | 3.85E−15 | Hypomethylated | 6.36E−21 | |
Hypermethylated with low expression |
FLNA
| Downregulated | 2.05E−29 | Hypermethylated | 6.99E−20 |
PRKCB
| Downregulated | 3.54E−37 | – | – |